Related by context. All words. (Click for frequent words.) 62 pre malignant lesions 59 Glioblastoma Multiforme GBM 59 validating biomarkers 58 STAT3 signaling 58 transfusion syndrome 58 TMPRSS2 ERG fusion 57 precursor lesions 57 phenotypic expression 57 Chronic pancreatitis 57 Umbilical cord stem cells 56 molecular determinants 56 Hutchinson Gilford progeria 56 metabolic disturbances 56 gastric carcinomas 56 DNA methylation patterns 56 insulin secreting beta 56 ischemic diseases 56 kidney urologic 56 molecular abnormalities 56 FGFs 56 Pseudomonas aeruginosa infections 56 polyomavirus nephropathy 56 NPM1 gene 56 renal fibrosis 56 potent inducer 56 underlying pathophysiology 56 premalignant 56 synovial cells 56 gene rearrangements 56 CYT# potent vascular disrupting 56 prognostic indicator 56 mitochondrial mutations 55 Pelvic inflammatory 55 signaling cascades 55 downregulating 55 neuroinflammatory 55 prolonged immobilization 55 podocyte 55 cytolytic 55 idiopathic pulmonary 55 malignant tissues 55 excitotoxic 55 fibrotic disease 55 nutlin 3a 55 TGF b 55 Glioblastoma multiforme GBM 55 tumoral 55 pancreatic endocrine 55 hematopoietic blood 55 glial tumors 55 collagen VII 55 hereditary predisposition 55 neovascularisation 55 epithelial barrier 55 metabolic enzymes 55 small molecule activators 55 myofibroblasts 55 malignant transformation 55 immune dysregulation 55 uterus womb 55 hemoglobinopathies 55 methylation markers 55 leukemic stem cells 55 NADPH oxidase 55 chemosensitivity 55 motor neuron degeneration 55 stratifying patients 54 prognostic markers 54 Cancer cachexia 54 myelofibrosis polycythemia vera 54 teratogens 54 chromosomal mutations 54 oncogenic transformation 54 Akt activation 54 EphB2 54 filaggrin 54 divide uncontrollably 54 p# activation 54 mitogen activated protein kinases 54 thymic carcinoma 54 Oxidative damage 54 arterial inflammation 54 precancerous condition 54 MTHFD1L 54 Alu RNA 54 Genetic variations 54 aldose reductase 54 presymptomatic 54 hyperactivated 54 oligodendrocyte progenitor cells 54 histone deacetylases 54 Smac mimetics 54 GRNOPC1 contains 54 Wnt signaling pathway 54 histone modifications 54 K ras mutations 54 mutated K ras 54 Colon polyps 54 proliferative disorders 54 oncoprotein 54 IDH mutations 54 dopaminergic cells 54 dyskeratosis congenita 54 beta globin gene 54 Epstein Barr virus EBV 54 Decoding genome 54 detecting coronary artery 54 Genetic predisposition 54 SIADH 54 antibody mediated 54 colorectal carcinoma 54 prognostic biomarkers 54 diagnostic biomarker 54 islet beta 54 neurofibroma 54 chromosome aberrations 54 brain lesions 54 amyloid protein plaques 54 alpha fetoprotein AFP 54 FGFR3 54 neoplastic cells 54 epigenetic alterations 54 p# MAPK 54 p# pathway 54 antiphospholipid syndrome 54 lung epithelium 54 apoptotic pathway 54 enzyme caspase 54 kidney fibrosis 54 amyloid deposition 54 intimal hyperplasia 53 MAPK pathway 53 leukaemic stem cells 53 uPAR 53 spontaneous regression 53 autoreactive T cells 53 lymphoid organs 53 diabetic kidney 53 hypervascular tumors 53 tumor suppressor protein 53 pyrimidines 53 Benign tumors 53 NPM1 mutation 53 ADVEXIN therapy 53 apoptosis programmed cell 53 dissolves blood clots 53 Hurthle cell 53 histone deacetylation 53 colorectal adenocarcinoma 53 redox active 53 γ secretase 53 intracellular pathogens 53 CMV infections 53 intracellular pathway 53 nitric oxide synthase 53 posttranslational modification 53 cytolytic activity 53 cervical lymph nodes 53 chemo resistant 53 dissolving blood clots 53 HER signaling pathway 53 selectively inhibited 53 thrombo embolic 53 immune modulator 53 nerve degeneration 53 tau aggregates 53 RKIP 53 leukocyte adhesion 53 malignant phenotype 53 VHL gene 53 lymphatic mapping 53 hormonally sensitive 53 retinoic acid receptor 53 VEGF induced 53 benign polyps 53 cellular organelles 53 cellular pathways 53 inducing apoptosis 53 metastatic uveal melanoma 53 periodontal tissues 53 immunological tolerance 53 PTEN gene 53 apoptosis induced 53 chronic inflammations 53 infectious prion proteins 53 Alpha synuclein 53 renal carcinoma 53 Basal cell 53 EGFR pathway 53 cisplatin resistant 53 misregulation 53 hedgehog pathway 53 Src kinase 53 pancreatic colon 53 lung fibrosis 53 Notch receptor 53 SCN9A 53 genomic alterations 53 genotoxic stress 53 Kufs disease 53 prognostic biomarker 53 Premature menopause 53 mammary cells 53 Cathepsin B 53 ADPKD 53 GIST tumors 53 hypermethylated 53 Akt3 53 hypereosinophilic syndrome 53 trophoblasts 53 endocrine dysfunction 53 CCR1 53 insulin secreting cells 53 unresectable tumors 53 N. gonorrhoeae 53 osteolytic 53 demethylation 53 cervical lymph node 53 underlying molecular mechanisms 53 extramedullary 53 chromosomal rearrangement 52 causative organisms 52 pancreas esophagus 52 prognostic marker 52 Raf kinase 52 CHD7 52 pulmonary metastases 52 subclinical disease 52 PDGF alpha receptor 52 IRS1 52 nonalcoholic steatohepatitis NASH 52 Von Willebrand disease 52 neuropsychological impairments 52 liver metastasis 52 histone deacetylase HDAC 52 Lymph node 52 neuroprotective therapies 52 WNT pathway 52 primary hyperparathyroidism 52 epithelial tumors 52 Stat5 52 Malignant glioma 52 inhibit angiogenesis 52 cAMP signaling 52 haematopoietic stem cells 52 druggable targets 52 inhibiting enzymes 52 DNA methyltransferases 52 excitotoxicity 52 breast cancer metastasis 52 tryptase 52 RNA splicing 52 virulence genes 52 M.tb 52 MAP kinase 52 pathological hallmark 52 podocytes 52 axonal damage 52 neoplastic 52 Notch receptors 52 FGFR1 52 cathepsins 52 mutant SOD1 52 NF kB pathway 52 dedifferentiation 52 Nurr1 52 DEAR1 52 lymphoid tissues 52 gamma globin gene 52 Angiotensin converting enzyme 52 initiates cascade 52 Dr. Bezprozvanny 52 GPC5 52 immunopathology 52 plexiform neurofibromas 52 TGF ß1 52 systemic amyloidosis 52 HER2 neu 52 biologic pathways 52 CVD cardiovascular disease 52 Mild hypothermia 52 anoikis 52 MMP inhibitors 52 epigenetic mechanisms 52 ARF1 52 platelet deficiency 52 cardiac fibrosis 52 Cryptococcus neoformans 52 genetic determinants 52 genetic locus 52 PCA3 gene 52 ischemia induced 52 neuronal dysfunction 52 Ribavirin causes 52 IgA deficiency 52 paroxysmal supraventricular tachycardia 52 genetic aberrations 52 p#INK#a 52 neoplastic diseases 52 Immunosuppressive drugs 52 biomarker identification 52 antimetastatic 52 glutamic acid decarboxylase 52 colonoscopic 52 da mage 52 overt nephropathy 52 causative genes 52 glucocorticoid receptors 52 carcinoid 52 breast cancer subtypes 52 CaM kinase II 52 beta islet cells 52 ubiquitin proteasome pathway 52 ischemic bowel 52 nerve sheath 52 PI3K AKT 52 spongiform encephalopathies 52 #beta HSD1 52 Ph + acute lymphoblastic 52 genomic biomarker 52 hyperacute 52 TRAIL induced apoptosis 52 thyroid hormone receptor 52 bony metastases 52 neuro degenerative disorders 52 beta1 integrin 52 cirrhotic liver 52 CCR3 52 clonogenic 52 papillary renal cell carcinoma 52 dysplastic lesions caused 52 mediated inhibition 52 DNA adducts 52 diagnose coronary artery 52 alpha1 antitrypsin deficiency 52 androgen receptor signaling 52 abnormal glucose metabolism 52 chronic granulomatous disease 52 enzymatic pathways 52 HER2 overexpression 52 p# mutations 52 poly ADP ribose polymerase 52 MEF2A 52 transcriptional machinery 51 prognostically 51 muscular dystrophies 51 immunodeficiency diseases 51 inhibit metastasis 51 beta amyloid peptide 51 Thrombotic thromboembolic complications 51 molecular underpinnings 51 proliferative diseases 51 mda 7 51 metabolic abnormality 51 MEK ERK 51 Pulmonary arterial hypertension 51 JAK mutations 51 embryonic germ 51 multiorgan 51 hypokalemia hypomagnesemia 51 Severe hypoglycemia 51 hepatic stellate cells 51 intracellular pathways 51 neuroendocrine cancers 51 transdifferentiation 51 TTR amyloidosis 51 mGluR5 antagonist 51 phosphate S1P 51 mutant huntingtin protein 51 micrometastasis 51 apolipoprotein E4 51 myocyte 51 scavenger cells 51 lung metastasis 51 Oxidative stress 51 predictive biomarkers 51 keloid scars 51 acinar 51 Pulmonary fibrosis 51 DLX5 51 predictive biomarker 51 JAK STAT pathway 51 DNA hypermethylation 51 Inhaled anthrax 51 Relapsing remitting MS 51 metastatic pancreatic 51 ERK1 2 51 tissue fibrosis 51 premalignant lesions 51 eotaxin 51 tumor metastasis 51 myeloproliferative diseases 51 bacterial biothreat agents 51 adhesion molecule EpCAM expressing 51 trophoblastic 51 pathogenic mechanisms 51 β cell 51 necrotizing pneumonia 51 secrete proteins 51 molar pregnancy 51 Fibrin MB 51 ductal carcinomas 51 myopathies 51 obstructive coronary 51 thyroid nodules 51 Genetic mutations 51 testicular tumors 51 cerebral ischemia 51 survivin expression 51 KRAS oncogene 51 squamous cell lung cancer 51 thyrotoxicosis 51 neural cells 51 hydrops 51 enteroviral infection 51 β catenin 51 adeno associated viruses 51 TMEM#B 51 Genetic variants 51 Plaque buildup 51 peroxisome 51 methyl D aspartate 51 airway epithelium 51 basophils 51 immunologically compatible 51 E selectin 51 JAK STAT signaling 51 toxic amyloid beta 51 mTOR inhibition 51 breast carcinomas 51 SOD2 gene 51 epithelial tissues 51 basal cell nevus syndrome 51 cyclic adenosine monophosphate cAMP 51 Nephrogenic Systemic Fibrosis NSF 51 gastrointestinal stromal tumor 51 tissue homeostasis 51 causative mutations 51 COX2 51 thromboembolic disease 51 Smad3 51 factor HGF 51 LRAT 51 urothelial cancer 51 IAP inhibitor 51 Akt signaling 51 intercellular adhesion molecule 51 carbohydrate antigens 51 lysyl oxidase 51 bronchoalveolar 51 fibrogenesis 51 cyclooxygenase COX 51 potent activator 51 Idiopathic pulmonary fibrosis IPF 51 Hsp# [001] 51 endosomal release 51 oncogenic pathways 51 Helicobacter infection 51 Cerebral palsy involves 51 cAMP pathway 51 Cystic fibrosis CF 51 lichen planus 51 directly degrades fibrin 51 Chronic inflammation 51 neurotrophic 51 prostate epithelial cells 51 glucocerebroside primarily 51 cardiac insufficiency 51 seminomas 51 anti angiogenic drugs 51 alvespimycin 51 PCNSL 51 cirrhosis liver cancer 51 HDAC inhibition 51 regulates gene expression 51 melanocyte stimulating hormone 51 neuro degenerative 51 HSF1 51 Dr. Rafii 51 promyelocytic leukemia 51 hyperplastic 51 Induced pluripotent stem cells 51 organophosphate exposure 51 Factor Receptor 51 serous ovarian cancer 51 serine proteases 51 PI3K signaling pathway 51 certain protein tyrosine 51 EGFR inhibitors 51 amyloid toxicity 51 coagulation disorders 51 renal cell carcinomas 51 leukocyte recruitment 51 neural degeneration 51 HGS ETR1 mapatumumab 51 JAK2 mutation 51 HIV reverse transcriptase 51 SOD1 gene 51 superoxide 51 degenerative neurological diseases 51 beta defensins 51 ankyrin repeat 51 Malignant tumors 51 epigenetic modification 51 neuronal differentiation 51 Raf MEK ERK 51 Epstein Barr Virus EBV 51 CDK5 51 atherothrombotic 51 Lupus nephritis 51 molecularly targeted therapies 51 proto oncogene 51 oncogenesis 51 transplanted islets 51 debilitating neurodegenerative disorder 51 Telomere shortening 51 nonhereditary 51 mitogen activated protein kinase 51 impair fertility 51 renal cysts 51 microtubule dynamics 51 Topoisomerase II 51 AT1R 51 E#F# 51 FGFR2 gene 51 chronic leukemias 51 selective inhibition 51 HH GLI 51 myeloproliferative disorders 51 antisense inhibitors 51 meningeal 51 secreting insulin 51 amyloid â 51 GATA3 51 cerebral angiography 51 Transcription factors 51 apoptotic cell 51 Diabetic neuropathy 50 airway hyperresponsiveness 50 thrombotic complications 50 environmental toxicants 50 ADAM# 50 ERK signaling 50 caveolin 1 50 HER2 expression 50 nonhuman primate model 50 postoperative pulmonary 50 M1 macrophages 50 engineered RAP peptides 50 N Myc 50 positional cloning 50 pathophysiological effects 50 cell signaling pathways 50 chronic hemolysis 50 activating mutations 50 MECP2 gene 50 coronary artery atherosclerosis 50 myelodysplasia 50 epithelial mesenchymal transition 50 pharmacologic approaches 50 ORMDL3 50 immunological mechanisms 50 insulitis 50 Lafora disease 50 pancreatic tissue 50 sporadic Creutzfeldt Jakob 50 monoclonal gammopathy 50 TMPRSS6 50 insoluble plaques 50 optimal dosing regimens 50 hydronephrosis 50 sortilin 50 tumor vascularization 50 prostate carcinoma 50 cirrhosis liver failure 50 Ionizing radiation 50 integrin activation 50 HER2 positivity 50 pharmacodynamic markers 50 PI3K pathway 50 cardio metabolic diseases 50 transgenic rats 50 mTOR kinase 50 tumor antigens 50 lowering blood glucose 50 Smac mimetic 50 vascular thrombosis 50 bone morphogenetic proteins BMPs 50 genetic loci 50 Systemic lupus erythematosus SLE 50 oncogenic signaling 50 Erythropoietic therapies may 50 FOXM1 50 teratoma 50 Aâ 50 NKX2 50 pulmonary thromboembolism 50 cancerdefine 50 MYCN amplification 50 secretes insulin 50 pancreatic alpha 50 embryonal rhabdomyosarcoma 50 intracellularly 50 mycotic 50 neurosteroid 50 Notch pathway 50 Misfolded proteins 50 ALK inhibitors 50 pilocytic astrocytomas 50 Clusterin 50 axonal regeneration 50 autoimmune reactions 50 bronchial inflammation 50 lymphangiogenesis 50 torsade de pointes 50 inflammatory bowel syndrome 50 seizures comas 50 FVIII inhibitors 50 novel VDA molecule 50 SHANK3 gene 50 fatty acid biosynthesis 50 dysrhythmias 50 activated microglia 50 viral inactivation 50 gliosis 50 prothrombotic 50 viral protease 50 arterial calcification 50 inherited retinal degeneration 50 Osteoclasts 50 histone methylation 50 Hemorrhagic strokes 50 pancreatic islet beta 50 nonfunctioning kidneys 50 androgen receptor AR 50 lymphatic vasculature 50 epigenetic regulation 50 fronto temporal dementia 50 amyloid deposits 50 HG PIN 50 hippocampal function 50 cholestasis 50 amyloid β peptide 50 VEGF receptor 50 epigenetic changes 50 surgical debulking 50 chitinase 50 neuromuscular junction 50 allogeneic HSCT 50 ERK pathway 50 estrogen receptor alpha 50 granzyme B 50 gene loci 50 synaptogenesis 50 Ras pathway 50 inherited retinal 50 microvascular disease 50 G6PD deficiency 50 diabetic retinopathy DR 50 Brodmann Area 50 Thyroid hormones 50 collagen vascular 50 prostate abnormalities 50 intestinal obstructions 50 choroidal melanoma 50 esophageal perforation 50 androgen signaling 50 PICALM 50 anergy 50 tumor subtypes 50 GATA4 50 carbohydrate intolerance 50 vascular abnormalities 50 acute humoral rejection 50 inhibits blood clotting 50 Tasigna prolongs 50 SIRT3 50 Macrophage 50 diffuse intrinsic pontine glioma 50 GABAergic interneurons 50 chemotaxis 50 carotid artery blockage 50 malignant pancreatic 50 haematopoietic 50 p# mitogen activated 50 neuro endocrine 50 pemphigus vulgaris 50 coagulation cascade 50 ras oncogene 50 retinal dysfunction 50 Oncogenic 50 NKG2D 50 nonvascular 50 PKC alpha 50 intestinal epithelium 50 Pten 50 gastric atrophy 50 multi factorial disease 50 liver scarring 50 PLX STROKE targeting 50 splice junctions 50 bone marrow lymph nodes 50 C1q 50 curative therapy 50 validate biomarkers 50 novel antiviral therapeutics 50 ovarian endometrial 50 Gleevec resistant 50 pulmonary metastasis 50 HCV NS5B polymerase 50 lymph node enlargement 50 Robo4 50 serine threonine 50 cofactors 50 chemokine receptor 50 somatic mutations 50 immunoregulatory 50 riociguat 50 poststroke depression 50 TTR gene 50 molecular subtypes 50 Francisella 50 cathepsin K 50 vWF 50 lymphoid cells 50 neuronal function 50 immunodeficiency disorders 50 Leber congenital amaurosis LCA 50 Wilms tumors 50 microvascular endothelial cells 50 periodontal tissue 50 endocrine glands 50 Fibroblast Growth Factor Receptor 50 thyroid deficiency 50 skin sparing mastectomy 50 neuroligins 50 #beta HSD 1 50 IGF IR 50 Poly ICLC 50 hepatocellular carcinoma liver 50 5 HT2A serotonin 50 pancreatic islet cell 50 mammary stem cells 50 Ischaemic heart 50 regenerative therapy 50 transcriptional activation 50 psoriatic plaques 50 cholesterol homeostasis 49 Ets2 49 keratinocyte 49 toxic megacolon 49 HepaMate ™ 49 5 HT4 49 serotonin uptake 49 adrenocortical cancer 49 CTNNB1 49 senescent cells 49 gastrointestinal mucositis 49 T lymphocytes 49 fatty acid oxidation 49 delipidation 49 myofibroblast 49 polymorphonuclear leukocytes 49 commercializing novel biotherapeutics 49 PPARγ 49 phagocytosis 49 missense mutations 49 embryonic tissues 49 submandibular gland 49 1 diabetes T1D 49 glioma cells 49 Pancreatic insufficiency 49 Dr. Victor Velculescu 49 delay bone metastases 49 decompensated cirrhosis 49 malignant prostate 49 organogenesis 49 MIF protein 49 abnormal p# 49 angiotensin receptor 49 neurotrophic factors 49 PI3K Akt 49 etiologic factors 49 Meningococcal infection 49 protein kinase C 49 GMX# 49 myelin insulation 49 lymphoid tumors 49 JAK2 enzyme 49 chronic bilirubin encephalopathy 49 protein tyrosine kinase 49 apoptotic pathways 49 cell adhesion molecule 49 Mdm2 49 C1 INH deficiency 49 undiagnosed celiac disease 49 5 HT2A receptor 49 pharmacologic intervention 49 lumbar disk herniation 49 tensin homolog 49 fatal neurodegenerative disorder 49 cytomegalovirus CMV 49 LIS1 49 innate immune responses 49 somatostatin receptor 49 pathogenetic 49 intestinal mucosa 49 CB2 receptor 49 polycythemia vera PV 49 terminally differentiated 49 immunological diseases 49 microRNA biomarkers 49 telomerase inhibitor 49 mutated EGFR 49 NS5b 49 microRNA molecules 49 mTOR mammalian target 49 pancreatic islet cells 49 genetic polymorphisms 49 lymphangioleiomyomatosis LAM 49 Upregulation 49 TGF beta signaling 49 NKT cells 49 proNGF 49 retinal pigment epithelium 49 CLL cells 49 sCJD 49 Immune cells 49 lymphotoxin 49 multisystem disease 49 IRAK1 49 vascular constriction 49 neurodegenerative disorder 49 debilitating complication 49 Inhaling asbestos fibers 49 genomic biomarkers 49 pulmonary hypertension PH 49 CCR9 antagonist 49 mesenchymal cell 49 Biosensor System revolutionary 49 bacillus anthracis 49 untreated celiac disease 49 induced anemia 49 underlying mechanisms Conney 49 systemic scleroderma 49 integrin receptors 49 Htt 49 protein synthesis machinery 49 channelopathies 49 neoplasm 49 neuronal degeneration 49 polycystin 49 immunosuppressive regimen 49 chromosome abnormality 49 ribonucleic acids 49 transthyretin TTR 49 BSE prions 49 protease enzymes 49 neuroblastoma tumors 49 chondrocyte 49 autophagic 49 NR#A# 49 regenerating tissues 49 neoplastic transformation 49 antitumor immune 49 myelogenous leukemia 49 selective kinase inhibitors 49 SMAD4 49 immunotherapeutic approaches 49 endogenous cannabinoids 49 Brugada syndrome 49 pleiotropic 49 treating cancerous tumors 49 PTLD 49 HNSCC 49 casein kinase 49 Uncontrolled hypertension 49 LPLD 49 cerebri 49 telomerase inhibitors 49 Dr. Ivashkiv 49 BRAF gene 49 narrowed carotid arteries 49 4E BP1 49 overactivated 49 hematologic disorders 49 abrupt cessation 49 atherosclerotic cardiovascular 49 pathophysiological mechanisms 49 neural progenitor cells 49 cystic fibrosis chronic pancreatitis 49 suppurative 49 treating neuropathic pain 49 RAS pathway 49 Cojocaru correspondent 49 chromosomal alterations 49 NLRP3 49 macrophage migration 49 Reactive oxygen species 49 hypothalamic pituitary adrenal axis 49 LHRH receptor positive 49 exocrine pancreas 49 overt hepatic encephalopathy HE 49 neuronal signaling 49 molecular biomarkers 49 endocrine therapies 49 biliary tree 49 esophagus colon 49 Hypoxia Inducible Factor 49 biochemical abnormalities 49 EMPOWER ™ 49 Adenoviruses usually cause 49 β cells 49 damage cirrhosis liver 49 gastro intestinal inflammation 49 EGF receptor 49 muscular dystrophy cystic fibrosis 49 microcirculatory 49 enzyme cyclooxygenase 49 Hepatocellular Carcinoma HCC 49 amyloid cascade 49 FLT3 49 immunomodulation 49 immuno modulatory 49 membranous nephropathy 49 vascular anatomy 49 hemophagocytic lymphohistiocytosis 49 HGPS 49 inherited predisposition 49 BCL2 49 branching morphogenesis 49 PNP inhibitor 49 fusion enhancers 49 polyglutamine diseases 49 amyloid proteins 49 Fragile X gene 49 Virulizin ® 49 Telomere length 49 dysfunction Zada 49 CDAD Clostridium difficile 49 cellular immunotherapy 49 RNAi therapeutic targeting 49 polymorphic ventricular tachycardia 49 neurite outgrowth 49 indwelling catheters 49 biliary obstruction 49 STAT3 49 lymphoproliferative disorder 49 pancreatic islet 49 type 1diabetes 49 vasculopathy 49 Thyroid gland 49 Thoroughly cooking eggs 49 Gleevec inhibits 49 TGR5 49 vitamin B1 deficiency 49 Urinary tract 49 Amyloid deposits 49 biochemical signaling pathways 49 alpha syn 49 activin 49 LDL receptor 49 Protein Kinase C 49 Dietary calcium 49 protein conformation 49 tumorigenicity 49 hematological indications 49 renal scarring 49 nonpharmacologic 49 molecular biomarker 49 acute hepatic 49 Membrane proteins 49 immunological reaction 49 ovarian carcinoma 49 epithelioid 49 Aromatase 49 CYP #A# 49 effector functions 49 collagen synthesis 49 MGd 49 stem cells CSCs 49 novel therapeutic antibodies 49 Mitral valve 49 hemodynamically stable 49 mitochondrial abnormalities 48 potent stimulator 48 RIGScan 48 etiological factors 48 renoprotective 48 OnDose TM 48 cerebral thrombosis 48 potent inhibitors 48 TGFβ 48 amyloidogenic 48 monogenic 48 microvasculature 48 PECAM 1 48 systemic autoimmune 48 Li Fraumeni